LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
Reporting ownerCIK 0001722140

Abraham Ceesay

39 transactions in 2 companies, from October 15, 2025 to October 7, 2026.

Transactions
392 companies
Bought · P
$0open market
Sold · S
$5.8Mopen market
Net
−$5.8Mnet selling

By company

Where this insider traded.

All transactions

39 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValue
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOOct 7SPLAN1,147$30.66$35K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOOct 6SPLAN3,375$32.03$108K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOSep 23SPLAN43$41.05$2K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOSep 23SPLAN215$39.86$9K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOSep 23SPLAN1,952$39.05$76K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOAug 25SPLAN18,921$49.57$938K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOAug 11SPLAN5,794$48.62$282K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOAug 11SPLAN19,500$48.04$937K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOAug 11SPLAN3,664$46.90$172K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOAug 10SPLAN8,370$46.75$391K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOAug 10SPLAN14,171$45.97$651K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOJul 27SPLAN7$42.74$299
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOJul 27SPLAN2,203$42.11$93K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOJul 14SPLAN2,729$40.57$111K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOJul 14SPLAN5,481$39.72$218K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOJun 29SPLAN876$40.34$35K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOJun 29SPLAN7,344$39.77$292K
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRLAbraham CeesayDirMay 8A1,438$177.62$255K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOFeb 18SPLAN2,100$29.80$63K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOFeb 18SPLAN2,983$29.04$87K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOFeb 18SPLAN2,281$29.80$68K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOFeb 18SPLAN3,552$29.05$103K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEODERIVFeb 2A428,000$0.00—?
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOJan 20SPLAN5,083$26.11$133K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOJan 20SPLAN5,833$26.12$152K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEODec 17SPLAN515$31.04$16K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEODec 17SPLAN2,421$30.04$73K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEODec 17SPLAN2,147$28.84$62K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEODec 17SPLAN600$31.04$19K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEODec 17SPLAN2,792$30.04$84K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEODec 17SPLAN2,441$28.84$70K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEONov 17SPLAN2,841$25.44$72K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEONov 17SPLAN2,242$24.91$56K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEONov 17SPLAN3,056$25.43$78K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEONov 17SPLAN2,777$24.92$69K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOOct 15SPLAN755$26.17$20K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOOct 15SPLAN4,328$25.75$111K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOOct 15SPLAN1,186$26.14$31K
Rapport Therapeutics, Inc.RAPPAbraham CeesayCEOOct 15SPLAN4,647$25.72$120K